Table 1

Matched cohort demographics and outcomes

Covariate, % (n) or mean (SE)Dronabinol cases (n=33)Non-dronabinol controls (n=33)P value
Males75.8 (25)69.7 (23)0.59
Mean age, years29.9 (1.7)30.0 (1.7)0.90
Mean injury severity score12.8 (1.3)15.7 (2.0)0.11
Cause of injury
 Vehicular crash45.5 (15)58.5 (16)1.00
 Fall cause30.3 (10)33.3 (11)1.00
 Other cause24.2 (8)18.2 (6)1.00
Surgical intervention63.6 (21)63.6 (21)1.00
Injury location/region
 Head injury48.5 (16)57.6 (19)0.58
 Chest injury39.4 (13)42.4 (14)1.0
 Abdominal injury18.2 (6)30.3 (10)0.39
 Spinal injury27.3 (9)54.6 (18)0.01
 Extremity75.8 (25)54.6 (18)0.12
Pre-injury marijuana user57.6 (19)12.1 (4)0.002
Pre-injury opioid user12.1 (4)3.0 (1)0.25
Pain management contract0 (0)0 (0)NA
Median (SE) hours to ‘post’period54.5 (9.6)48 (0)0.11
Mean baseline* MME168.8 (18.2)129.6 (15.7)0.07
Mean baseline* pain5.8 (0.3)4.9 (0.3)0.05
Mean hospital LOS, days9.3 (1.1)11.4 (1.5)0.17
Mean ICU LOS, days2.2 (0.5)4.0 (1.1)0.12
  • P value: McNemar's test for categorical variables, paired t-test for continuous variables, Wilcoxon rank sum test for medians. The values in bold indicate statistical significance.

  • *Baseline: 48 hours before dronabinol (cases) and 0–48 hours from admission (controls).

  • ICU, intensive care unit; LOS, length of stay; MME, morphine milligram equivalents.